Literature DB >> 30896834

miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7.

Jia-Zhen Tang1, Xiao Lin2, Jia-Yu Zhong2, Feng Xu3, Feng Wu4, Xiao-Bo Liao5, Rong-Rong Cui3, Fuxingzi Li3, Ling-Qing Yuan3.   

Abstract

MicroRNAs (miRNAs) are novel key regulators of cellular differentiation. miR‑124 has been reported to regulate osteogenic differentiation of bone marrow‑derived mesenchymal stem cells (BMSCs). However, the specific mechanisms involved have not yet been fully elucidated. The present study aimed to investigate the effect of miR‑124 on osteogenic differentiation of BMSCs and its underlying mechanisms. In the present study, it was found that alkaline phosphatase (ALP) activity, osteocalcin (OC) secretion, and the protein levels of osterix (Sp7) and runt‑related transcription factor 2 (Runx2) were significantly increased, whereas the expression of miR‑124 was decreased in a time‑dependent manner during osteogenic differentiation of BMSCs. Following overexpression of miR‑124 via transfection of miR‑124 mimics in BMSCs, Runx2 protein expression and ALP activity were significantly decreased. By contrast, inhibition of miR‑124 expression led to an increase in ALP activity and Runx2 expression. Sp7 expression was suppressed in BMSCs transfected with miR‑124 mimics while increased when miR‑124 expression was inhibited, indicating that miR‑124 regulates the expression of Sp7. Moreover, a luciferase reporter assay further verified that Sp7 is the direct target of miR‑124. Finally, the effect of miR‑124 inhibitor on promoting the differentiation of BMSCs was abolished following treatment with a small interfering RNA targeting Sp7. Taken together, the present study demonstrates that miR‑124 inhibits the osteogenic differentiation of BMSCs by targeting Sp7.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30896834     DOI: 10.3892/mmr.2019.10054

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

2.  Systematic Analysis of mRNAs and ncRNAs in BMSCs of Senile Osteoporosis Patients.

Authors:  Yiyun Geng; Jinfu Chen; Chongfei Chang; Yifen Zhang; Li Duan; Weimin Zhu; Lisha Mou; Jianyi Xiong; Daping Wang
Journal:  Front Genet       Date:  2021-12-20       Impact factor: 4.599

Review 3.  Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells.

Authors:  Jicheng Wang; Shizhang Liu; Jingyuan Li; Song Zhao; Zhi Yi
Journal:  Stem Cell Res Ther       Date:  2019-06-28       Impact factor: 6.832

4.  Novel Nanohydroxyapatite (nHAp)-Based Scaffold Doped with Iron Oxide Nanoparticles (IO), Functionalized with Small Non-Coding RNA (miR-21/124) Modulates Expression of Runt-Related Transcriptional Factor 2 and Osteopontin, Promoting Regeneration of Osteoporotic Bone in Bilateral Cranial Defects in a Senescence-Accelerated Mouse Model (SAM/P6). PART 2.

Authors:  Krzysztof Marycz; Agnieszka Śmieszek; Katarzyna Kornicka-Garbowska; Ariadna Pielok; Maciej Janeczek; Anna Lipińska; Anna Nikodem; Jarosław Filipiak; Paulina Sobierajska; Jean-Marie Nedelec; Rafał J Wiglusz
Journal:  Int J Nanomedicine       Date:  2021-08-31

5.  Bone marrow stromal cells (BMSCs CD45- /CD44+ /CD73+ /CD90+ ) isolated from osteoporotic mice SAM/P6 as a novel model for osteoporosis investigation.

Authors:  Mateusz Sikora; Agnieszka Śmieszek; Krzysztof Marycz
Journal:  J Cell Mol Med       Date:  2021-06-01       Impact factor: 5.310

Review 6.  Small and Long Non-coding RNAs as Functional Regulators of Bone Homeostasis, Acting Alone or Cooperatively.

Authors:  Mateusz Sikora; Krzysztof Marycz; Agnieszka Smieszek
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-15       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.